控制权交易落空，永和智控开启“卖卖卖”模式

Core Viewpoint - Yonghe Intelligent Control has initiated a series of asset sales following the abrupt termination of its control change plan, raising significant market attention [1][4]. Group 1: Asset Sale Details - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary, Kunming Medical Oncology Hospital, with a minimum listing price of 35.93 million CNY [1]. - This marks the fourth time Yonghe Intelligent Control has publicly listed its oncology hospital assets for sale in the past 12 months, including the transfer of stakes in various other hospitals [2]. - The assessed net assets of Kunming Medical as of July 31, 2025, are 32.45 million CNY, with an appraisal value of 35.93 million CNY, reflecting an increase of 3.47 million CNY and a growth rate of 10.70% [1][2]. Group 2: Financial Performance - For the first seven months of 2025, Kunming Medical reported revenue of 11.58 million CNY and a net loss of 6.59 million CNY, continuing a trend of losses from 2024 [2][3]. - Yonghe Intelligent Control's revenue for the first three quarters of 2025 was 582 million CNY, a year-on-year decline of 7.25%, with a net loss attributable to shareholders of 60.46 million CNY [5]. Group 3: Control Change Attempt - The control change plan involving the transfer of 8% of the company's shares for 320 million CNY was terminated due to the buyer's failure to pay the initial installment [3]. - This was the third failed attempt by the current controlling shareholder to change ownership since taking control in 2019 [3].